383 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Allergan/Gedeon's Vraylar Gets FDA Nod for Mental Disorders http://www.zacks.com/stock/news/190652/allergan-gedeons-vraylar-gets-fda-nod-for-mental-disorders?cid=CS-ZC-FT-190652 Sep 18, 2015 - Allergan (AGN) and Gedeon Richter Plc. announced that the FDA has approved Vraylar for the treatment of bipolar I disorder and schizophrenia in adults.
Apricus Up after Regaining Vitaros U.S. Rights from Allergan http://www.zacks.com/stock/news/189832/apricus-up-after-regaining-vitaros-us-rights-from-allergan?cid=CS-ZC-FT-189832 Sep 11, 2015 - Apricus Biosciences' (APRI) shares gained 7.7% after the company regained the U.S. development and commercialization rights to Vitaros from Allergan.
Apricus Biosciences (APRI) Looks Good: Stock Jumps 7.7% http://www.zacks.com/stock/news/189719/shares-of-apricus-biosciences-apri-rose-roughly-8in-the-last-session?cid=CS-ZC-FT-189719 Sep 11, 2015 - Apricus Biosciences (APRI) was a big mover last session with its shares rising roughly 8% on the day.
Allergan (AGN) to Buy Eye Care Device Company AqueSys http://www.zacks.com/stock/news/189101/allergan-agn-to-buy-eye-care-device-company-aquesys?cid=CS-ZC-FT-189101 Sep 04, 2015 - Allergan plc (AGN) announced that it has entered into an agreement to acquire AqueSys, Inc.
AstraZeneca Ties Up for FluMist, CAZ-AVI Scores; Shares Up http://www.zacks.com/stock/news/188840/astrazeneca-ties-up-for-flumist-caz-avi-scores-shares-up?cid=CS-ZC-FT-188840 Sep 03, 2015 - AstraZeneca (AZN) signs up with Daiichi Sankyo for FluMist Quadrivalent in Japan; reports positive phase III data on antibiotic drug CAZ-AVI.
Allergan Buys Naurex, Boosts Mental Health Portfolio http://www.zacks.com/stock/news/188559/allergan-buys-naurex-boosts-mental-health-portfolio?cid=CS-ZC-FT-188559 Sep 01, 2015 - Allergan (AGN) acquires central nervous system focused company, Naurex, to boost mental disorder portfolio.
Stock Market News for September 01, 2015 http://www.zacks.com/stock/news/188481/stock-market-news-for-september-01-2015?cid=CS-ZC-FT-188481 Sep 01, 2015 - Benchmarks ended in the red on Monday after Federal Vice Chairman Stanley Fischer’s comments on Saturday left possibilities of September rate hike wide open
Stock Market News for August 31, 2015 http://www.zacks.com/stock/news/188321/stock-market-news-for-august-31-2015?cid=CS-ZC-FT-188321 Aug 31, 2015 - Benchmarks ended Friday’s choppy trading session little changed amid another surge in oil prices and Fed official’s comment on the timing of a rate hike
Stock Market News for August 27, 2015 http://www.zacks.com/stock/news/187975/stock-market-news-for-august-27-2015?cid=CS-ZC-FT-187975 Aug 27, 2015 - Benchmarks scored a multi-record percentage gain on Wednesday following strong durable-goods report and comments from a Fed official that a September rate hike seems inappropriate
Eli Lilly's Alimta Patent Upheld by U.S. District Court http://www.zacks.com/stock/news/187860/eli-lillys-alimta-patent-upheld-by-us-district-court?cid=CS-ZC-FT-187860 Aug 26, 2015 - Eli Lilly and Company announced that it has received a favorable ruling in a lawsuit related to the infringement of vitamin regimen patent for Alimta.

Pages: 1...33343536373839

<<<Page 38